Superparamagnetic Particles Global Market Report 2025

The superparamagnetic particles market size has grown rapidly in recent years. It will grow from $1.23 billion in 2024 to $1.38 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to the increasing use of magnetic resonance imaging, growing research in nanomedicine, rising adoption of diagnostic tools, an increase in cancer research and treatment, and a rise in government funding for medical research.

The superparamagnetic particles market size is expected to see rapid growth in the next few years. It will grow to $2.17 billion in 2029 at a compound annual growth rate (CAGR) of 12%. The growth in the forecast period can be attributed to increasing demand for targeted drug delivery, rising use of magnetic resonance imaging, growing adoption of biosensors and diagnostic tools, increasing applications in hyperthermia treatment for cancer, and rising collaborations between research organizations and industry players. Major trends in the forecast period include advancements in biomedical imaging, advanced applications in drug delivery, innovation in cancer diagnostics, integration with nanotechnology, and advancements in magnetic resonance imaging.

The growing demand for personalized medicine is expected to drive the expansion of the superparamagnetic particles market in the coming years. Personalized medicine refers to a medical approach that customizes treatment and healthcare decisions based on an individual’s genetic profile, lifestyle, and environment to enhance treatment outcomes and minimize side effects. The demand for personalized medicine is increasing due to advancements in genetic testing and precision diagnostics, which enable healthcare professionals to tailor therapies for each patient. Superparamagnetic particles play a key role in personalized medicine by supporting targeted drug delivery, molecular imaging, and diagnostic applications, ultimately contributing to improved therapeutic results. For instance, in February 2024, the Personalized Medicine Coalition, a United States-based non-profit organization, reported that in 2023, the United States Food and Drug Administration approved 16 new personalized treatments for patients with rare diseases, up from six in 2022, including seven cancer therapies and three for other medical conditions. Therefore, the growing demand for personalized medicine is driving the growth of the superparamagnetic particles market.

Key companies operating in the superparamagnetic particles market are focusing on developing advanced solutions, such as imaging agents, to enable non-invasive visualization of internal body structures. Imaging agents are substances that enhance the contrast of specific tissues or organs in medical imaging to improve diagnostic accuracy. For instance, in December 2023, Imagion Biosystems Limited, an Australia-based medical imaging company, announced positive outcomes following the completion of its IBI10103 phase I clinical trial. The study evaluated the safety and clinical feasibility of the MagSense HER2 Imaging Agent (MSH2IA) as an adjunct to MRI for detecting axillary lymph node metastasis in patients with HER2-positive primary breast cancer. This imaging agent is based on a core of superparamagnetic iron oxide nanoparticles produced at Imagion’s GMP-compliant facility in San Diego, California. The nanoparticles are coated with biocompatible polymers and conjugated to the monoclonal antibody trastuzumab (Herceptin). MSH2IA is administered as a single injection near the primary tumor site and travels through the lymphatic system, selectively binding to HER2-positive breast cancer cells to improve MRI visualization.

In July 2024, Hologic Inc., a United States-based medical technology company, acquired Endomagnetics Ltd. for 310 million dollars. Through this acquisition, Hologic aims to enhance and diversify its oncology portfolio by incorporating Endomagnetics Ltd’s magnetic surgical technologies, thereby strengthening its expertise in advanced cancer diagnostics, minimally invasive treatment solutions, and comprehensive patient care across multiple oncological fields. Endomagnetics Ltd. is a United Kingdom-based manufacturer of products containing superparamagnetic particles.

Major players in the superparamagnetic particles market are Thermo Fisher Scientific Inc., Sigma-Aldrich Co. LLC, Agilent Technologies Inc., Miltenyi Biotec B.V. & Co. KG, GenScript Biotech Corporation, Promega Corporation, JSR Life Sciences LLC, American Elements, Bioclone Inc., Spherotech Inc., Techinstro, nanoComposix Inc., Bang Laboratories, Nanoshel Llc, Cytodiagnostics Inc., Micromod Partikeltechnologie GmbH, Ocean NanoTech LLC, ProSciTech Pty Ltd., Biosensis Pty Ltd., BOC Sciences Ltd., MagQu Co. Ltd.

North America was the largest region in the superparamagnetic particles market in 2024. The regions covered in superparamagnetic particles report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The intensifying U.S. tariffs and escalating trade tensions in spring 2025 are expected to have a significant impact on the chemicals sector, which is bearing a disproportionate burden, particularly from tariffs on petrochemicals and intermediates, where affordable domestic substitutes are often unavailable. Producers of specialty chemicals, heavily dependent on Chinese raw materials, are experiencing production disruptions. At the same time, fertilizer manufacturers are seeing profit margins eroded due to tariffs on phosphate imports. In response, companies are ramping up R&D into bio-based alternatives, forming procurement alliances to consolidate buying power, and shifting production to tariff-neutral nations such as Saudi Arabia.

The superparamagnetic particles market research report is one of a series of new reports that provides superparamagnetic particles market statistics, including superparamagnetic particles industry global market size, regional shares, competitors with a superparamagnetic particles market share, detailed superparamagnetic particles market segments, market trends and opportunities, and any further data you may need to thrive in the superparamagnetic particles industry. This superparamagnetic particle market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Superparamagnetic particles are nanosized magnetic materials, typically composed of iron oxides, that exhibit magnetic properties only when exposed to an external magnetic field. They become magnetized in the presence of the field but lose magnetization once the field is removed. Owing to their small size and strong magnetic responsiveness, they are extensively utilized in biomedical applications such as MRI contrast agents, drug delivery, and magnetic separation.

The primary types of superparamagnetic particles include iron oxide particles, cobalt ferrite particles, nickel ferrite particles, magnetite particles, and others. Iron oxide particles refer to minute particles composed of iron and oxygen that possess magnetic characteristics and are commonly used in biomedical, industrial, and environmental applications. They are available in various sizes, including nanoscale (less than 100 nm), microscale (100 nm to 1 μm), and sub-microscale (1 μm to 10 μm), and are distributed through direct sales, distributors and resellers, online retailers, and third-party platforms. They find applications in biomedical uses, magnetic resonance imaging (MRI), drug delivery systems, biosensors, and magnetic separation, serving end-user industries such as healthcare and life sciences, environmental applications, the food and beverage industry, electronics and consumer goods, and chemicals and pharmaceuticals.

The countries covered in the superparamagnetic particles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The superparamagnetic particles market consists of sales of dynabeads, magnetic separators and racks, dextran-coated magnetic beads, magnetic hyperthermia nanoparticles, and silica-coated magnetic nanoparticles. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.